The DOI matches its Crossref record.
Fibrin(ogen) in cardiovascular disease: an update
Abstract
Summary: The notion that fibrinogen is strongly, consistently, and independently related to cardiovascular risk has been widely accepted. The evidence is based on numerous prospective epidemiological studies and clinical observations. In meta-analysis, an association between even modest increases (10%) in fibrino-gen and future coronary heart disease (CHD) endpoints has been found with an odds ratio for CHD of 1.8; 95% CI, 1.6 to 2.0, if the top tertile of the fibrinogen distribution was compared to the bottom tertile; but fibrinogen levels were also associated with unstable and stable coronary artery disease, and coronary complications after interventions. Similar results have been obtained for incident stroke, progression of peripheral arterial disease, and finally for total mortality. The reasons however, why fibrinogen is elevated in cardiovascular disease and in atherosclerosis in general, are only incompletely under-stood; but all cells involved in the atherogenetic process are able to produce cytokines which induce an acute phase reaction, and thus increase fibrinogen plasma levels. The potential pathophysiological mechanisms by which elevated fibrinogen levels mediate cardiovascular risk are manyfold: It forms the substrate for thrombin and represents the final step in the coagulation cascade; it is essential for platelet aggregation; it modulates endothelial function;it promotes smooth muscle cell proliferation and migration; it interacts with the binding of plas-min with its receptor, and finally it represents a major acute phase protein. Whether or not fibrinogen is causally involved in atherothrombogenesis still remains to be determined, and even though other unsolved issues await conclusive answers, fibrino-gen has emerged as an important additional marker of cardiovascular risk. Theme paper: Part of this paper was originally presented at the joint meetings of the 16th International Congress of the International Society of Fibrinolysis and Proteolysis (ISFP) and the 17th International Fibrinogen Workshop of the International Fibrinogen Research Society (IFRS) held in Munich, Germany, September, 2002.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Diabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443
(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227
IMHOF, A., WOODWARD, M., DOERING, A., HELBECQUE, N., LOEWEL, H., AMOUYEL, P., LOWE, G., & KOENIG, W. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.032 · Cited by 204
PCSK9 and inflammation: a review of experimental and clinical evidence
Momtazi-Borojeni, A. A., Sabouri-Rad, S., Gotto, A. M., Pirro, M., Banach, M., Awan, Z., Barreto, G. E., & Sahebkar, A. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz022 · Cited by 188
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Metadata
- Authors
- Koenig, W.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003
- Volume
- 89
- Issue
- 04
- Pages
- 601-609
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1720454525
- Cited by
- 285
- References
- 0
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibrin(ogen) in cardiovascular disease: an update. https://app.cochat.ai/papers/10.1055/s-0037-1613566
- The paper
- Koenig, W. (2003). Fibrin(ogen) in cardiovascular disease: an update. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1613566
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.